These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1825793)

  • 1. Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases.
    Jernigan TL; Salmon DP; Butters N; Hesselink JR
    Biol Psychiatry; 1991 Jan; 29(1):68-81. PubMed ID: 1825793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.
    Fennema-Notestine C; Archibald SL; Jacobson MW; Corey-Bloom J; Paulsen JS; Peavy GM; Gamst AC; Hamilton JM; Salmon DP; Jernigan TL
    Neurology; 2004 Sep; 63(6):989-95. PubMed ID: 15452288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral structure on MRI, Part I: Localization of age-related changes.
    Jernigan TL; Archibald SL; Berhow MT; Sowell ER; Foster DS; Hesselink JR
    Biol Psychiatry; 1991 Jan; 29(1):55-67. PubMed ID: 2001446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional subcortical shape analysis in premanifest Huntington's disease.
    Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
    Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
    Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
    Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study.
    Starkstein SE; Brandt J; Bylsma F; Peyser C; Folstein M; Folstein SE
    Neuroradiology; 1992; 34(6):487-9. PubMed ID: 1436456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
    Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
    Rosas HD; Koroshetz WJ; Chen YI; Skeuse C; Vangel M; Cudkowicz ME; Caplan K; Marek K; Seidman LJ; Makris N; Jenkins BG; Goldstein JM
    Neurology; 2003 May; 60(10):1615-20. PubMed ID: 12771251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
    Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
    Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter volume and cognitive dysfunction in early Huntington's disease.
    Beglinger LJ; Nopoulos PC; Jorge RE; Langbehn DR; Mikos AE; Moser DJ; Duff K; Robinson RG; Paulsen JS
    Cogn Behav Neurol; 2005 Jun; 18(2):102-7. PubMed ID: 15970729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senile plaques in Huntington's disease: a preliminary report.
    Bruyn GW; Roos RA
    Clin Neurol Neurosurg; 1990; 92(4):329-31. PubMed ID: 1963823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.
    Mann DM; Oliver R; Snowden JS
    Acta Neuropathol; 1993; 85(5):553-9. PubMed ID: 8493863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.